Lyka Labs Limited Passes All Five Resolutions at 47th Annual General Meeting

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights

Lyka Labs Limited held its 47th AGM on 10th August 2026 via video conferencing, with all five ordinary resolutions passed by requisite majority through e-voting. Key approvals included adoption of audited financial statements for FY ended 31st March 2026, re-appointment of Mr. Shashil Philip Mendonsa as Director, ratification of cost auditor remuneration for FY 2025-2026 and FY 2026-2027, and approval of material related party transactions with IPCA Laboratories Limited for FY 2026-27. The total votes polled for Resolutions 1 through 4 stood at over 22 million, with approximately 99.99% in favour, while Resolution 5 recorded 1034655 votes in favour (99.84%) with promoters abstaining as interested parties.

powered bylight_fuzz_icon
48009017

*this image is generated using AI for illustrative purposes only.

Lyka Labs Limited successfully held its 47th Annual General Meeting (AGM) on Monday, 10th August 2026, at 12:30 P.M. through Video Conference/Other Audio-Visual Means (VC/OAVM). All five resolutions placed before the shareholders were passed with the requisite majority via remote e-voting and e-voting during the meeting. The scrutinizing process was conducted by Kaushal Doshi, Practicing Company Secretary and Proprietor of M/s. Kaushal Doshi & Associates, appointed by the Board of Directors vide resolution dated 25th May 2026.

Meeting Participation and Voting Overview

The record date for determining eligible shareholders was 3rd August 2026, with a total of 29,814 shareholders on record. Attendance at the meeting was entirely through video conferencing, with no shareholders present in person or through proxy. The following table summarises meeting attendance:

Parameter: Details
Date of AGM: 10th August 2026
Mode: Video Conference / OAVM
Record Date: 3rd August 2026
Total Shareholders on Record Date: 29,814
Promoter & Promoter Group (VC): 10
Public Shareholders (VC): 56
Total Resolutions Passed: 5

The remote e-voting period commenced on Thursday, 6th August 2026 at 09:00 A.M. and ended on Sunday, 9th August 2026 at 5:00 P.M. NSDL was appointed as the service provider for the e-voting facility.

Summary of Resolutions and Voting Results

All five resolutions were ordinary resolutions. The voting results, as certified by the Scrutinizer, are summarised below:

Item No.: Resolution Description: Votes in Favour (Persons) Votes in Favour (Votes) % in Favour Votes Against (Persons) Votes Against (Votes) % Against
1 Adoption of Audited Financial Statements (Standalone & Consolidated) for FY ended 31st March 2026 73 22136077 99.99 3 1651 0.01
*2 Re-appointment of Mr. Shashil Philip Mendonsa (DIN: 09667654) as Director 72 22136076 99.99 3 1651 0.01
3 Ratification of Remuneration of Cost Auditor for FY 2025-2026 73 22136077 99.99 3 1651 0.01
4 Ratification of Remuneration of Cost Auditor for FY 2026-2027 72 22135077 99.99 3 1651 0.01
*5 Approval of Material Related Party Transactions with IPCA Laboratories Limited for FY 2026-27 52 1034655 99.84 3 1651 0.16

Interested Directors, their relatives, and other related parties abstained from voting.

Resolution-wise Voting Details

For Resolutions 1, 2, 3, and 4, the total votes polled across all categories stood at over 22 million, reflecting strong participation primarily from the Promoter and Promoter Group category. The detailed category-wise breakdown for Resolution 1 is as follows:

Category: Shares Held Votes Polled % Polled Votes in Favour Votes Against
Promoter & Promoter Group: 21132392 21099217 99.843 21099217 0
Public – Institutions: 293264 0 0 0 0
Public – Non Institutions: 14727055 1038511 7.0517 1036860 1651
Total: 36152711 22137728 61.2339 22136077 1651

For Resolution 5, concerning approval of material related party transactions with IPCA Laboratories Limited for FY 2026-27, the Promoter and Promoter Group abstained from voting as interested parties. As a result, the total votes polled for this resolution stood at 1036306, representing 2.8665% of outstanding shares, with 1034655 votes (99.8407%) cast in favour and 1651 votes (0.1593%) against.

Key Resolutions at a Glance

The five resolutions passed at the 47th AGM covered the following key matters:

  • Adoption of Financial Statements: Both standalone and consolidated audited financial statements for the financial year ended 31st March 2026, along with the Reports of the Board of Directors and Auditors, were adopted.
  • Director Re-appointment: Mr. Shashil Philip Mendonsa (DIN: 09667654), who retired by rotation, was re-appointed as Director.
  • Cost Auditor Remuneration – FY 2025-2026: Ratification of the remuneration of the Cost Auditor for FY 2025-2026 was approved.
  • Cost Auditor Remuneration – FY 2026-2027: Ratification of the remuneration of the Cost Auditor for FY 2026-2027 was approved.
  • Related Party Transactions: Approval of material related party transactions with IPCA Laboratories Limited for the Financial Year 2026-27 was granted, with interested directors, their relatives, and other related parties abstaining from voting.

The Scrutinizer's Report was issued on 10th August 2026 and the consolidated e-voting results were submitted to the stock exchanges in compliance with Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Company Secretary and Compliance Officer, Shailendra Agrawal, confirmed that all resolutions were carried with the requisite majority.

Historical Stock Returns for Lyka Labs

1 Day5 Days1 Month6 Months1 Year5 Years
+1.99%+6.82%+22.74%+29.12%-22.47%+6.32%

How will the approved material related party transactions with IPCA Laboratories Limited impact Lyka Labs' supply chain efficiency and profit margins in FY 2026-27?

Given the low participation rate from public non-institutional shareholders (approx. 7%), what measures might management implement to improve retail investor engagement in future governance matters?

What strategic initiatives or capital allocation plans are expected to be detailed in the upcoming quarterly earnings following the adoption of the FY 2025-26 financial statements?

Lyka Labs seeks approval for ₹75 crore IPCA transactions at AGM

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights

Lyka Labs Limited has scheduled its 47th Annual General Meeting for August 10, 2026, via video conferencing. The meeting will seek shareholder approval for material related party transactions with promoter IPCA Laboratories Limited worth up to ₹75 crore for FY 2026-27. Additionally, shareholders will vote on the ratification of remuneration for the cost auditor and the adoption of audited financial statements for FY26.

powered bylight_fuzz_icon
45861293

*this image is generated using AI for illustrative purposes only.

Lyka Labs Limited will hold its 47th Annual General Meeting (AGM) on Monday, 10 August 2026, at 12.30 p.m. through Video Conferencing and Other Audio Visual Means (VC/OAVM). Shareholders will vote on the ratification of cost auditor remuneration and approve material related party transactions with IPCA Laboratories Limited for FY 2026-27. The approval for transactions with the promoter, IPCA Laboratories Limited, is sought for an aggregate value not exceeding ₹75,00,00,000.

The company has dispensed with sending physical copies of the notice and Annual Report for the financial year 2025-26, adhering to relevant MCA and SEBI circulars. The Annual Report for FY26 is accessible on the company’s website, www.lykalabs.com . The remote e-voting period commences at 9.00 a.m. on Thursday, 6 August 2026, and concludes at 5.00 p.m. on Sunday, 9 August 2026.

Business to be Transacted

The ordinary business includes the adoption of the audited financial statements for the year ended 31 March 2026 and the appointment of a director in place of Mr. Shashil Philip Mendonsa, who retires by rotation and is eligible for re-appointment.

Special business includes the ratification of remuneration for the Cost Auditor, Messrs Nidhi Subhash Tibrewala & Co., for FY 2025-26 and FY 2026-27. The remuneration is fixed at ₹1,60,000 plus applicable taxes and out-of-pocket expenses for each financial year. The previous cost auditor, Messrs Rajaram Madhav Walavalakar & Co, resigned effective 5 March 2026.

Related Party Transactions

Shareholders will consider an ordinary resolution to approve material related party transactions with IPCA Laboratories Limited, a promoter of the company. The transactions, which include the sale and purchase of raw materials, contract manufacturing, and inter-corporate deposits, are proposed for an aggregate value of ₹75 crore for FY 2026-27. The Audit Committee and Board of Directors have reviewed and recommended the transactions, stating they are in the ordinary course of business and on an arm’s length basis.

Key Dates for AGM Proceedings

Event Date and Time
AGM Date Monday, 10 August 2026 at 12.30 p.m.
Remote E-voting Start Thursday, 6 August 2026 at 9.00 a.m.
Remote E-voting End Sunday, 9 August 2026 at 5.00 p.m.
Cut-off Date Monday, 3 August 2026

Shailendra Kumar Agrawal, Company Secretary and Compliance Officer, is the point of contact for any grievances related to electronic voting.

Historical Stock Returns for Lyka Labs

1 Day5 Days1 Month6 Months1 Year5 Years
+1.99%+6.82%+22.74%+29.12%-22.47%+6.32%

How will the ₹75 crore limit for related party transactions with IPCA Laboratories impact Lyka Labs' operational flexibility and cost structures in FY 2026-27?

What strategic benefits does Lyka Labs expect from the expanded scope of transactions, including inter-corporate deposits, with its promoter IPCA Laboratories?

Will the change in cost auditor influence the company's internal audit practices or financial reporting standards for the upcoming fiscal years?

More News on Lyka Labs

1 Year Returns:-22.47%